Implementation of an Outpatient HD-MTX Initiative

Sokol, K; Yuan, KL; Piddoubny, M; Sweeney, E; Delengowski, A; Fendler, K; Espinosa, G; Alberto, J; Galanis, P; Gung, C; Stokley, M; George, M; Harris, M; Martinez-Outschoorn, U; Alpdogan, O; Porcu, P; Binder, AF

Binder, AF (通讯作者)，Thomas Jefferson Univ, Div Hematol Malignancies & Hematopoiet Stem Cell, Dept Med Oncol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.

FRONTIERS IN ONCOLOGY, 2022; 11 ():

Abstract

IntroductionMethotrexate (MTX) a folate antagonist is often given in high doses (>= 500 mg/m(2)) to treat a variety of disease processes. While inp......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索